Log In
Print
BCIQ
Print
Print this Print this
 

S-555739

  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionProstaglandin D2 (PGD2) receptor (CRTH2; GPR44; CD294) antagonist
Molecular Target Prostaglandin D2 (PGD2) receptor subtype DP2 (PTGDR2) (CRTH2) (GPR44) (DP2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationAllergy
Indication DetailsTreat allergic disease; Treat allergic rhinitis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today